Frequent MED12 mutations in phyllodes tumours of the breast

Por Yoshida, M, Sekine, S, Ogawa, R, Yoshida, H, Maeshima, A, Kanai, Y, Kinoshita, T, Ochiai, A
Publicado no Br J Cancer (2015)

Prolonged lymphocytopenia after bendamustine therapy in patients with relapsed or refractory indolent B-cell and mantle cell lymphoma

Por Saito, H, Maruyama, D, Maeshima, A M, Makita, S, Kitahara, H, Miyamoto, K, Fukuhara, S, Munakata, W, Suzuki, T, Kobayashi, Y, Taniguchi, H, Tobinai, K
Publicado no Blood Cancer J (2015)

Prolonged lymphocytopenia after bendamustine therapy in patients with relapsed or refractory indolent B-cell and mantle cell lymphoma

Por Saito, H, Maruyama, D, Maeshima, A M, Makita, S, Kitahara, H, Miyamoto, K, Fukuhara, S, Munakata, W, Suzuki, T, Kobayashi, Y, Taniguchi, H, Tobinai, K
Publicado no Blood Cancer J (2017)

Impact of the double expression of MYC and BCL2 on outcomes of localized primary gastric diffuse large B-cell lymphoma patients in the rituximab era

Por Kawajiri, A, Maruyama, D, Maeshima, A M, Nomoto, J, Makita, S, Kitahara, H, Miyamoto, K-i, Fukuhara, S, Suzuki, T, Munakata, W, Tajima, K, Itami, J, Taniguchi, H, Kobayashi, Y, Tobinai, K
Publicado no Blood Cancer J (2016)